Conference Track

Managing HCC and Liver Transplantation

Source: CCO Independent Conference Coverage of the 2005 Annual Meeting of the American Association for the Study of Liver Diseases*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Capsule Summaries

Higher Mortality Rate, More Allograft Failure in Patients Receiving Liver Transplants from Nonheart-Beating Donors
Virological Response and Resistance to Adefovir Therapy in Liver Transplant Recipients
PELD Score Underutilized for Pediatric Transplant Liver Allocation
Retransplant Candidates Not Disadvantaged Under MELD System
HCV-Infected Patients Have Similar Outcomes With Living and Deceased Donor Liver Transplantation at Experienced Transplant Centers
Higher Recurrence Rates Among Hepatocellular Carcinoma Patients Undergoing Living Donor Liver Transplants Compared With Deceased Donor Liver Transplants
Early Liver Transplantation May Prevent Cardiac Amyloidosis in Familial Amyloid Polyneuropathy Patients With TTR Met30 Variant
Interferon Alfa-2b Treatment After Curative Resection of HCC from HBV-HCV Does Not Improve Survival Rates
Nodule Size and Number Predict Outcome in HCC Transplant Patients
TACE-Induced Tumor Reduction Associated with Lowered Post-Transplant Survival
Almost All Patients Declined Participation in Randomized Controlled Trial of HCC Screening
Improved Survival With Screening for Hepatocellular Carcinoma in Chronic Hepatitis B and Liver Cirrhosis
Use of Laparoscopic Radiofrequency Ablation Results in Successful Bridging to Liver Transplantation in Patients With Hepatocellular Carcinoma
Sustained Virologic Response After Interferon Monotherapy Associated With Lower Risk of HCC and Mortality in Patients With HCV-Related Child’s Class A Cirrhosis

Expert Analysis

Managing HCC and Liver Transplantation

Faculty:

Norah Terrault, MD, MPH
Paul Martin, MD
Robert J. Fontana, MD

Learning Objectives

Upon completion of this activity, participants should be able to:

Review the latest approaches to diagnosis and monitoring of HCC.
Discuss the advantages and disadvantages of different types of liver transplantation.
Describe various strategies for treating patients with HCC in order to improve their options for liver transplantation.

CME CREDIT INFORMATION

Release Date: 01/27/06

Expiration Date: 01/26/07

Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Registered Nurses: 1.6 Nursing CE credits

Status: Please log in to view status

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.